Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy

Erstveröffentlichung
2020Authors
Di Cosimo, Serena
Appierto, Valentina
Pizzamiglio, Sara
Silvestri, Marco
Baselga, Jose
Wissenschaftlicher Artikel
Published in
International Journal of Molecular Sciences ; 21 (2020), 4. - Art.-Nr. E1386. - eISSN 1422-0067
Link to publication
https://dx.doi.org/10.3390/ijms21041386Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: circulating microRNAs | biomarkers | HER2 | breast cancer | trastuzumab | ct-miR-148a-3p | PATHOLOGICAL COMPLETE RESPONSE | TUMOR ANGIOGENESIS | REGULATORY CIRCUIT | MIR-148A | SENSITIVITY | EXPRESSION | LAPATINIB | RESISTANCE | PATHWAYS | NEOALTTO[DDC subject group]: DDC 540 / Chemistry & allied sciences | DDC 570 / Life sciences